Share on: 
Website: eGenesis

Our science is utilizing the process of xenotransplantation, which is the grafting or transplanting of organs or tissues between members of different species. eGenesis seeks to make this process a clinical reality by harnessing the company’s CRISPR technology platform to deliver safe and effective human transplantable cells, tissues and organs grown in pigs. The eGenensis approach includes the following process steps: genome engineering on pig cells, organ maturation in the bioreactor (pig) and organ transplantation.

Career Page(s): 
Cambridge MA
United States